CTOs on the Move

Huupe

www.huupe.com

 
Founded in 2016, Huupe is the first-ever smart basketball hoop. It brings competition and training to basketball enthusiasts and players, including NBA athletes as well as stars from the league who have invested in the company. Huupe`s groundbreaking innovation enables ages eight and up to compete on the court or virtually, learn and improve their skills, track their progress, and more. The appointment of Paul as CTO follows the company`s 400% growth month over month in the past six months this year, with 50% growth in October 2022 alone, and viral popularity on social media.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Ample Scientific

Ample Scientific is a Norcross, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Revolution Health Group

Revolution Health Group LLC is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bardavon

Bardavon Health Innovations is a proactive Workers` Compensation partner that connects all stakeholders to better manage claims. We offer work readiness solutions through rehabilitation therapy. We share a holistic analysis of the claim so America`s injured workers can achieve optimized functional outcomes and return to full-duty.

National Health Foundation

Established in 1973, the National Health Foundation (NHF) is an innovative leader in seeking ways to improve the healthcare delivery system. One of the Foundation's first initiatives was the development of a bioengineering program for hospitals. This

Fractyl Laboratories

At Fractyl, we are focused on improving the health of people with Type 2 diabetes. We`ve created an innovative clinical procedure based on new insights into the root cause of the disease. We are currently engaged in clinical trials designed to prove that our innovative procedure can dramatically improve glucose control and reduce the need for additional medications. Our mission is to set people free from the daily burdens of Type 2 diabetes management, empower physicians with a safe and reliable therapeutic treatment, and lower the tremendous human and financial costs of diabetic complications for patients, hospitals, and payers.